Health
Inhalable nanobody shows potent anti-SARS-CoV-2 activity in vivo – News-Medical.Net
Researchers have developed a stable and ultrapotent homotrimeric Pittsburgh inhalable Nanobody 21 (PiN-21) against SARS-CoV-2 infection in Syrian hamsters. They…
Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), are being administered worldwide. A successful, safe and targeted therapeutic drug to treat this infection is yet to emerge.
Convalescent plasma, repurposed antivirals, neutralizing monoclonal antibodies, and highly selected nanobodies (Nbs) and multivalent forms are some of the innovative therapeutics tried against this virus.
However, these attempts to arrive…
-
Noosa News17 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
General19 hours agoFirst home buyers score early access to deposit scheme
-
Noosa News18 hours agoForum responds to urgent homelessness issues in Nambour
-
General17 hours agoEnergy provider ENGIE to ‘correct’ electricity bills for thousands of South Australian customers